Skip to main content
Tamara Moyo, MD, Oncology, Charlotte, NC, Atrium Health's Carolinas Medical Center

TamaraKayMoyoMD

Oncology Charlotte, NC

Physician

Dr. Moyo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moyo's full profile

Already have an account?

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2017
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2010 - 2012
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2010

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2017 - 2024
  • NC State Medical License
    NC State Medical License 2019 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation Cohort
    Tamara Moyo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart¬ Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients
    Tamara Moyo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association
    TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology AssociationJune 1st, 2018
  • TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 58th American Society of Hematology Annual Meeting
    TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 58th American Society of Hematology Annual MeetingNovember 3rd, 2016
  • Study Identifies New Culprit in Lung Cancer Development
    Study Identifies New Culprit in Lung Cancer DevelopmentJanuary 27th, 2016

Hospital Affiliations